Welcome to CDC Stacks | Staphylococcus aureus Colonization and Long-Term Risk for Death, United States - 42807 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Staphylococcus aureus Colonization and Long-Term Risk for Death, United States
Filetype[PDF - 823.08 KB]


Details:
No Related Documents.
You May Also Like:
  1. Methicillin-Resistant Staphylococcus aureus Colonization of the Groin and Risk for Clinical Infection among HIV-infected Adults
    Personal Author:
    Peters, Philip J.; Brooks, John T.; McAllister, Sigrid K.; Limbago, Brandi; Lowery, H. Ken; Fosheim, Gregory; Guest, Jodie L.; Gorwitz, Rachel J.; Bethea, Monique; Hageman, Jeffrey; Mindley, Rondeen; McDougal, Linda K.; Rimland, David;
    Published:
    Apr 2013
    Source:
    Emerg Infect Dis. 19(4):623-629.
    Description:
    Data on the interaction between methicillin-resistant Staphylococcus aureus (MRSA) colonization and clinical infection are limited. During 2007-2008, we enrolled HIV-infected adults in Atlanta, Georgia, USA, in a prospective cohort study. Nares and g...
    File Type:
    Filetype[PDF - 619.73 KB]
  2. Methicillin-Resistant Staphylococcus aureus USA300 Clone in Long-Term Care Facility
    Personal Author:
    Tattevin, Pierre; Diep, Binh An; Jula, Michael; Perdreau-Remington, Françoise;
    Published:
    Jun 2009
    Source:
    Emerg Infect Dis. 15(6):953-955.
    Description:
    We performed a longitudinal analysis of 661 methicillin-resistant Staphylococcus aureus (MRSA) isolates obtained from patients in a long-term care facility. USA300 clone increased from 11.3% of all MRSA isolates in 2002 to 64.0% in 2006 (p<0.0001) an...
    File Type:
    Filetype[PDF - 402.90 KB]
  3. Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients1
    Personal Author:
    Weber, Stephen G.; Gold, Howard S.; Hooper, David C.; Karchmer, A.W.; Carmeli, Yehuda;
    Published:
    Nov 2003
    Source:
    Emerg Infect Dis. 9(11):1415-1422.
    Description:
    To determine whether fluoroquinolone exposure is a risk factor for the isolation of Staphylococcus aureus and whether the effect is different for methicillin-resistant S. aureus (MRSA) versus methicillin--susceptible S. aureus (MSSA), we studied two ...
    File Type:
    Filetype[PDF - 258.93 KB]
  4. Fluoroquinolones and Risk for Methicillin-Resistant Staphylococcus aureus, Canada
    Personal Author:
    LeBlanc, Louiselle; Pépin, Jacques; Toulouse, Krystel; Ouellette, Marie-France; Coulombe, Marie-Andrée; Corriveau, Marie-Pier; Alary, Marie-Eve;
    Published:
    Sep 2006
    Source:
    Emerg Infect Dis. 12(9):1398-1405.
    Description:
    Receipt of fluoroquinolones was the predominant risk factor for Clostridium difficile-associated disease (CDAD) during an epidemic in Quebec, Canada. To determine the role of antimicrobial drugs in facilitating healthcare-associated methicillin-resis...
    File Type:
    Filetype[PDF - 343.64 KB]
  5. FIGURES 5-10 for: Characteristics of initial prescription episodes and likelihood of long-term opioid use — United States, 2006–2015
    Published:
    March 17, 2017
    Source:
    Shah A, Hayes CJ, Martin BC. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015. MMWR Morb Mortal Wkly Rep 2017;66(10):265-269.
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 66, no. 10, p.
    Description:
    FIGURE 5. One- and 3-year probabilities of opioid use by duration of first episode in weeks (modifying opioid discontinuation definition). : FIGURE 6. One-and three-year probabilities of opioid use by duration of first episode in days (modifying opio...
    File Type:
    Filetype[PDF - 236.56 KB]